95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.41%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-9.76%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-6.19%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.19%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-5.33%
Negative net income growth while RGLD stands at 8.32%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.71%
Negative EPS growth while RGLD is at 8.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.71%
Negative diluted EPS growth while RGLD is at 8.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.14%
Share count expansion well above RGLD's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.09%
Diluted share count expanding well above RGLD's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-1.99%
Negative OCF growth while RGLD is at 18.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
15.97%
FCF growth under 50% of RGLD's 89.72%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
17.83%
10Y revenue/share CAGR under 50% of RGLD's 116.72%. Michael Burry would suspect a lasting competitive disadvantage.
48.43%
5Y revenue/share CAGR 1.25-1.5x RGLD's 33.62%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
57.84%
3Y revenue/share CAGR above 1.5x RGLD's 26.27%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-6.51%
Negative 10Y OCF/share CAGR while RGLD stands at 172.33%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
61.94%
5Y OCF/share CAGR at 50-75% of RGLD's 83.85%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
86.47%
3Y OCF/share CAGR 1.25-1.5x RGLD's 65.94%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-17.41%
Negative 10Y net income/share CAGR while RGLD is at 207.62%. Joel Greenblatt sees a major red flag in long-term profit erosion.
115.73%
Below 50% of RGLD's 253.19%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
218.03%
3Y net income/share CAGR 1.25-1.5x RGLD's 168.24%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
76.72%
10Y equity/share CAGR above 1.5x RGLD's 29.88%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
24.80%
5Y equity/share CAGR 1.25-1.5x RGLD's 17.26%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
23.93%
3Y equity/share CAGR similar to RGLD's 25.32%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
44.13%
Below 50% of RGLD's 128.35%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
119.91%
5Y dividend/share CAGR above 1.5x RGLD's 45.64%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
82.04%
3Y dividend/share CAGR above 1.5x RGLD's 32.00%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-46.31%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
61.49%
Inventory growth well above RGLD's 55.15%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.33%
Negative asset growth while RGLD invests at 2.27%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.92%
Under 50% of RGLD's 1.90%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-9.45%
We’re deleveraging while RGLD stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-44.46%
We cut SG&A while RGLD invests at 4.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.